The Newcastle upon Tyne Hospitals
About Us
Newcastle Hospitals NHS Foundation Trust is one of the busiest, largest and most successful teaching NHS foundation trusts in the country, with around 16,000 staff and an annual income of £1billion.
We have a strong history of providing high-quality care, clinical excellence, and innovation in medical research regionally, nationally and internationally.
We’re also proud to be the second largest provider of specialised services in the country, supporting people with a range of rare and complex medical, surgical and neurological conditions, cancers and genetic orders.
Our staff oversee around 6,000 patients contacts every day, delivering high standards of healthcare from:
- Freeman Hospital
- Royal Victoria Infirmary (RVI)
- The Campus for Ageing and Vitality (former Newcastle General Hospital site)
- Newcastle Dental Hospital
- Newcastle Fertility Centre
- Northern Centre for Cancer Care, North Cumbria
- Northern Genetics Service
- Cramlington Manor Walks
We are proud to nurture a culture of innovation and pioneering care, through our range of flagship services which are supported by state-of-the-art diagnostics in both radiology and pathology.
Leaders in research, development and pioneering treatments - We are leaders in healthcare research and development across a wide range of specialisms, delivering benefits not only for today’s patients but for generations to come.
Our partnership working with Newcastle University focuses on key areas which are important to all our futures, including stem cell research, genetics, ageing and vitality.
Much of our research is only possible through the important partnerships we also have with patients, other NHS organisations, universities, the local authority and charitable bodies.
Through our strong focus on clinical research, we are able to stay at the forefront of pioneering treatments such as transplantation, and mitochondrial donation at the Newcastle Fertility Centre – a form of IVF in which the future baby’s mitochondrial DNA comes from a donor egg to avoid inherited diseases – and PrEP (Pre-exposure prophylaxis, a drug to prevent HIV).
Newcastle patients, both children and adults, were amongst the first in the world to receive CAR-T cell therapy, which marks a new era of personalised medicine for treating lymphoma and leukaemia.